Merrihew Charis, Kumar Bhavna, Heretis Katherine, Rueger David C, Kuettner Klaus E, Chubinskaya Susan
Department of Biochemistry, Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, 1653, W. Congress Parkway, Chicago, IL 60612, USA.
J Orthop Res. 2003 Sep;21(5):899-907. doi: 10.1016/S0736-0266(03)00055-X.
A synchronized balance between synthesis and breakdown of extracellular matrix (ECM) molecules in normal articular cartilage is disturbed in osteoarthritis (OA). The focus of our study is the anabolic factor, osteogenic protein-1 (OP-1) that is expressed in articular cartilage and is able to induce the synthesis of ECM components. The major aim was to investigate both qualitatively and quantitatively endogenous OP-1 in normal, degenerative, and OA cartilage. Normal and degenerative cartilage was obtained at autopsies from femoral condyles of human organ donors with no documented history of joint disease; OA cartilage was obtained from patients undergoing joint arthroplasty. Appearance of donor cartilage was evaluated by Collins scale, where normal cartilage is assigned grades 0-1, and degenerated cartilage is assigned grades 2-4. OP-1 mRNA expression was assessed by RT-PCR; OP-1 protein (pro- and active forms) was qualitatively analyzed by Western blotting and quantified by OP-1 ELISA. The highest levels of OP-1 expression (mRNA and protein) were detected in normal cartilage of grade 0. The concentration of OP-1 protein was about 50 ng per gram cartilage dry weight. With the progression of cartilage degeneration (increased Collins grades and OA) OP-1 protein was down-regulated up to 9-fold. These changes affected primarily the active form of OP-1. OP-1 message also declined in cartilages with the increase of degenerative changes. In conclusion, an overall decrease in endogenous OP-1 in degenerated and OA tissue suggests that OP-1 could be one of the factors responsible for normal homeostasis and matrix integrity in cartilage.
在骨关节炎(OA)中,正常关节软骨细胞外基质(ECM)分子合成与分解之间的同步平衡被打破。我们研究的重点是合成代谢因子骨生成蛋白-1(OP-1),它在关节软骨中表达,并能够诱导ECM成分的合成。主要目的是定性和定量研究正常、退变和OA软骨中的内源性OP-1。正常和退变软骨取自无关节疾病记录的人体器官捐献者股骨髁的尸检标本;OA软骨取自接受关节置换术的患者。捐献者软骨的外观通过柯林斯评分评估,其中正常软骨评为0-1级,退变软骨评为2-4级。通过RT-PCR评估OP-1 mRNA表达;通过蛋白质印迹法定性分析OP-1蛋白(前体和活性形式),并通过OP-1 ELISA进行定量分析。在0级正常软骨中检测到最高水平的OP-1表达(mRNA和蛋白质)。OP-1蛋白的浓度约为每克软骨干重50 ng。随着软骨退变的进展(柯林斯评分增加和OA),OP-1蛋白下调高达9倍。这些变化主要影响OP-1的活性形式。随着退变变化的增加,软骨中的OP-1信息也下降。总之,退变和OA组织中内源性OP-1的总体下降表明,OP-1可能是维持软骨正常稳态和基质完整性的因素之一。